Primary Site >> Liver Cancer
Gene >> RRM2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79. PMID: 18641988 |
Ref: Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. PMID: 20388846 Ref: RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). PMID: 20798514 |
Ref: Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. PMID: 24060417 |
Ref: High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma. PMID: 25368754 |
Ref: Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials. PMID: 26379829 |
Ref: SCYL1-BP1 affects cell cycle arrest in human hepatocellular carcinoma cells via Cyclin F and RRM2. PMID: 25980818 Ref: Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein. PMID: 26774458 |
Ref: Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. PMID: 28640074 |
Ref: Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with Melicope ptelefolia leaf extract reveals transcriptome profiles exhibiting anticancer activity. PMID: 30042885 Ref: An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposomeprotamine-DNA-siRNA complex with cell permeable peptides. PMID: 30106091 |